Insmed Incorporated (NASDAQ:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported financial results for the fourth …
Insmed Incorporated (NASDAQ:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported financial results for the third …
Insmed Incorporated (NASDAQ:INSM), a global biopharmaceutical company focused on the needs of patients with rare diseases today announced the launch of NTM Facts, an …
In a research report released today, Piper Jaffray’s healthcare analyst Joshua Schimmer reiterated an Overweight rating on shares of Insmed Incorporated (NASDAQ:INSM) with a …
Insmed Incorporated (NASDAQ:INSM), a global biopharmaceutical company focused on the needs of patients with rare diseases today reported two ARIKAYCE™ (liposomal amikacin for inhalation) …
Recently, various executives have taken part in insider selling activity for the stocks of LinkedIn Corp (NYSE:LNKD), Yelp Inc (NYSE:YELP), Insmed Incorporated (NASDAQ:INSM), …
H.C.
In a research report published Monday, Piper Jaffray analyst Joshua Schimmer maintained an Overweight rating on Insmed Incorporated (NASDAQ:INSM) with a $51 price target, …
In a research report released this morning, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Insmed Incorporated (NASDAQ:INSM) with a $51 price …
In a report issued today, H.C.
